Literature DB >> 30457203

Fitting algorithms and baseline correction influence the results of non-invasive in vivo quantitation of 2-hydroxyglutarate with 1 H-MRS.

Katharina J Wenger1, Elke Hattingen2, Patrick N Harter3, Christian Richter4, Kea Franz5, Joachim P Steinbach1, Oliver Bähr1, Ulrich Pilatus6.   

Abstract

1 H-MRS enables non-invasive detection of 2-hydroxyglutarate (2-HG), an oncometabolite accumulating in gliomas carrying mutations in the isocitrate dehydrogenase (IDH) genes. Reliable 2-HG quantitation requires reproducible post-processing, deployment of fitting algorithms and quantitation methods. We prospectively enrolled 38 patients with suspected or recently diagnosed gliomas (IDH mutated n = 26). The MRI protocol included a 1 H single voxel PRESS sequence with volumes of usually 8 mL or more (20 × 20 × 20 mm3 ) at TE  = 97 ms and 180° pulse spacing. Our aim was to evaluate the reliability of 2-HG quantitation comparing two frequently used software tools and their respective options of baseline correction (jMRUI with the time domain methods AQSES and QUEST, and LCModel, which analyzes the frequency domain data). For AQSES, degrees of freedom for baseline correction constrains were varied. For LCModel, baseline correction was obtained with and without correction of the unknown background term (predefined macromolecules, lipids). Tissue concentrations were calculated based on the phantom replacement method. Quantitation of 2-HG levels showed similar mean 2-HG tissue concentrations for IDH mutated tumors (2.65mM, range 3.06-2.20) for all methods. Bland-Altman plots (difference plots) did not reveal a systematic bias (fixed bias) for any of the algorithms tested, and we were able to show a significant correlation regarding 2-HG concentration at the same echo time with few statistical outliers (parametric correlation). However, evaluation of outliers suggested that in vivo quantitation of 2-HG is affected not only by the fitting domain (time or frequency), but also by the baseline correction, which is a major contributing factor to the result of 2-HG fitting. Clinical application of 2-HG quantitation as a prognostic or predictive biomarker, particularly in multicenter trials, requires standardized use of fitting methods and baseline correction procedures.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  1H-MRS; 2-hydroxyglutarate; glioma; mutations in the IDH genes; post-processing analysis

Mesh:

Substances:

Year:  2018        PMID: 30457203     DOI: 10.1002/nbm.4027

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  4 in total

1.  Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas.

Authors:  K J Wenger; J P Steinbach; O Bähr; U Pilatus; E Hattingen
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-09       Impact factor: 3.825

2.  Optimization of spectrally selective 180° radiofrequency pulse timings in J-difference editing (MEGA) of lactate.

Authors:  Sandeep K Ganji; Zhongxu An; Vivek Tiwari; Yongmin Chang; Toral R Patel; Elizabeth A Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2021-10-17       Impact factor: 4.668

3.  Comparison of different linear-combination modeling algorithms for short-TE proton spectra.

Authors:  Helge J Zöllner; Michal Považan; Steve C N Hui; Sofie Tapper; Richard A E Edden; Georg Oeltzschner
Journal:  NMR Biomed       Date:  2021-02-02       Impact factor: 4.044

Review 4.  Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.

Authors:  Deling Li; Chirag B Patel; Guofan Xu; Andrei Iagaru; Zhaohui Zhu; Liwei Zhang; Zhen Cheng
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.